Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STAT proteins are a family of latent cytoplasmic transcription factors that, upon activation by cytokine or growth factor signaling, are phosphorylated, dimerize, and translocate to the nucleus where they regulate gene expression. They are essential for processes such as immune cell development, proliferation, and the response to inflammation. Dysregulation of STAT signaling, especially STAT3 and STAT5, is implicated in various cancers, chronic inflammation, and immune system disorders. For structured data purposes, it is recommended to specify the exact STAT protein (e.g., "Signal transducer and activator of transcription 3" for STAT3 or "Signal transducer and activator of transcription 5A" for STAT5A), as each family member can have distinct biological roles and therapeutic relevance.
Inhibition of dimerization or tetramerization of STAT proteins Inhibition of tyrosine phosphorylation to prevent activation Blockade of DNA binding to target genes Inhibition of upstream activators, such as JAK kinases
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal transducer and activator of transcription protein family member (STAT (for family); specific members are STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6).